Send to

Choose Destination
See comment in PubMed Commons below
FEBS Lett. 2008 Jul 23;582(17):2583-8. doi: 10.1016/j.febslet.2008.06.030. Epub 2008 Jun 25.

Molecular mechanism of Zn2+ agonism in the extracellular domain of GPR39.

Author information

University of Copenhagen, Faculty of Health Sciences, Department of Neuroscience and Pharmacology, Laboratory for Molecular Pharmacology, Blegdamsvej 3b, Copenhagen N, Denmark.


Ala substitution of potential metal-ion binding residues in the main ligand-binding pocket of the Zn2+-activated G protein-coupled receptor 39 (GPR39) receptor did not decrease Zn2+ potency. In contrast, Zn2+ stimulation was eliminated by combined substitution of His17 and His19, located in the N-terminal segment. Surprisingly, substitution of Asp313 located in extracellular loop 3 greatly increased ligand-independent signaling and apparently eliminated Zn2+-induced activation. It is proposed that Zn2+ acts as an agonist for GPR39, not in the classical manner by directly stabilizing an active conformation of the transmembrane domain, but instead by binding to His17 and His19 in the extracellular domain and potentially by diverting Asp313 from functioning as a tethered inverse agonist through engaging this residue in a tridentate metal-ion binding site.

[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center